Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting
- PMID: 21666406
- PMCID: PMC3312468
- DOI: 10.1086/660763
Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting
Abstract
Risk factors for development of intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) may differ between those who acquire the organism via patient-to-patient transmission versus by antibiotic selective pressure. The aim of this study was to quantify potential risk factors for the development of IRPA not due to patient-to-patient transmission.
Conflict of interest statement
Similar articles
-
Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.Acta Pharmacol Sin. 2008 Dec;29(12):1486-92. doi: 10.1111/j.1745-7254.2008.00892.x. Acta Pharmacol Sin. 2008. PMID: 19026168
-
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.J Korean Med Sci. 2008 Dec;23(6):982-7. doi: 10.3346/jkms.2008.23.6.982. Epub 2008 Dec 24. J Korean Med Sci. 2008. PMID: 19119440 Free PMC article.
-
The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit.J Infect Dis. 2009 Sep 15;200(6):900-5. doi: 10.1086/605408. J Infect Dis. 2009. PMID: 19673646 Free PMC article.
-
Contribution of tap water and environmental surfaces to nosocomial transmission of antibiotic-resistant Pseudomonas aeruginosa.Infect Control Hosp Epidemiol. 2004 Apr;25(4):342-5. doi: 10.1086/502402. Infect Control Hosp Epidemiol. 2004. PMID: 15108733 Review. No abstract available.
-
Epidemiology of infections due to Pseudomonas aeruginosa.Rev Infect Dis. 1984 Sep-Oct;6 Suppl 3:S627-42. doi: 10.1093/clinids/6.supplement_3.s627. Rev Infect Dis. 1984. PMID: 6443765 Review.
Cited by
-
Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit.World J Clin Cases. 2023 May 6;11(13):2874-2889. doi: 10.12998/wjcc.v11.i13.2874. World J Clin Cases. 2023. PMID: 37215420 Free PMC article. Review.
-
Comorbidity and severity-of-illness risk adjustment for hospital-onset Clostridioides difficile infection using data from the electronic medical record.Infect Control Hosp Epidemiol. 2021 Aug;42(8):955-961. doi: 10.1017/ice.2020.1344. Epub 2020 Dec 17. Infect Control Hosp Epidemiol. 2021. PMID: 33327970 Free PMC article.
-
Risk factors for acquisition of carbapenem-resistance during treatment with carbapenem in the intensive care unit: a prospective study.Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2077-2085. doi: 10.1007/s10096-019-03644-6. Epub 2019 Sep 3. Eur J Clin Microbiol Infect Dis. 2019. PMID: 31482416 Free PMC article.
-
Gram-negative infections: evolving treatments with expanding options.Future Sci OA. 2018 Sep 27;4(9):FSO339. doi: 10.4155/fsoa-2018-0071. eCollection 2018 Oct. Future Sci OA. 2018. PMID: 30416747 Free PMC article.
-
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 29997889 Free PMC article.
References
-
- Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect.Control Hosp.Epidemiol. 2008;29:996–1011. - PubMed
-
- Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin- resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158:1127–1132. - PubMed
-
- Lepelletier D, Caroff N, Riochet D, et al. Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients. Eur.J.Clin.Microbiol.Infect.Dis. 2006;25:600–603. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01RR16500/RR/NCRR NIH HHS/United States
- K08 HS018111/HS/AHRQ HHS/United States
- K24AI079040/AI/NIAID NIH HHS/United States
- R01 AI060859-05A1/AI/NIAID NIH HHS/United States
- K23 AI082450/AI/NIAID NIH HHS/United States
- 1K08 HS18111-01/HS/AHRQ HHS/United States
- 1K12RR02350-03/RR/NCRR NIH HHS/United States
- K01AI071015-02/AI/NIAID NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- KL2 RR024141/RR/NCRR NIH HHS/United States
- R01 AI060859/AI/NIAID NIH HHS/United States
- K24 AI079040/AI/NIAID NIH HHS/United States
- R01A1060859/PHS HHS/United States
- K01 AI071015/AI/NIAID NIH HHS/United States
- KL2RR024141/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical